| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |